These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38290569)

  • 1. Remimazolam attenuates inflammation and kidney fibrosis following folic acid injury.
    Song J; Yu W; Chen S; Huang J; Zhou C; Liang H
    Eur J Pharmacol; 2024 Mar; 966():176342. PubMed ID: 38290569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IRF-4 deficiency reduces inflammation and kidney fibrosis after folic acid-induced acute kidney injury.
    Chen M; Wen X; Gao Y; Liu B; Zhong C; Nie J; Liang H
    Int Immunopharmacol; 2021 Nov; 100():108142. PubMed ID: 34555644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and pharmacological inhibition of fatty acid-binding protein 4 alleviated inflammation and early fibrosis after toxin induced kidney injury.
    Li L; Tao S; Guo F; Liu J; Huang R; Tan Z; Zeng X; Ma L; Fu P
    Int Immunopharmacol; 2021 Jul; 96():107760. PubMed ID: 33991998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jmjd3/IRF4 axis aggravates myeloid fibroblast activation and m2 macrophage to myofibroblast transition in renal fibrosis.
    Liang H; Liu B; Gao Y; Nie J; Feng S; Yu W; Wen S; Su X
    Front Immunol; 2022; 13():978262. PubMed ID: 36159833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer T cell/IL-4 signaling promotes bone marrow-derived fibroblast activation and M2 macrophage-to-myofibroblast transition in renal fibrosis.
    Liu B; Jiang J; Liang H; Xiao P; Lai X; Nie J; Yu W; Gao Y; Wen S
    Int Immunopharmacol; 2021 Sep; 98():107907. PubMed ID: 34243040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-8 counteracts folic acid-induced acute kidney injury and prevents its transition to fibrosis.
    Perez-Moreno E; Toledo T; Campusano P; Zuñiga S; Azócar L; Feuerhake T; Méndez GP; Labarca M; Pérez-Molina F; de la Peña A; Herrera-Cid C; Ehrenfeld P; Godoy AS; González A; Soza A
    Biomed Pharmacother; 2024 Aug; 177():116923. PubMed ID: 38936192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological inhibition of SETD7 by PFI-2 attenuates renal fibrosis following folic acid and obstruction injury.
    Liu B; Nie J; Liang H; Liang Z; Huang J; Yu W; Wen S
    Eur J Pharmacol; 2021 Jun; 901():174097. PubMed ID: 33848540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF-1R inhibition attenuates ischemia-induced renal injury and fibrosis by reducing Ly6C
    Deng X; Yang Q; Wang Y; Zhou C; Guo Y; Hu Z; Liao W; Xu G; Zeng R
    Int Immunopharmacol; 2020 Nov; 88():106854. PubMed ID: 32771945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oleoylethanolamide attenuates acute-to-chronic kidney injury: in vivo and in vitro evidence of PPAR-α involvement.
    Comella F; Lama A; Pirozzi C; Annunziata C; Piegari G; Sodano F; Melini S; Paciello O; Lago Paz F; Meli R; Mattace Raso G
    Biomed Pharmacother; 2024 Feb; 171():116094. PubMed ID: 38183745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow-derived Ly6C
    Yang Q; Wang Y; Pei G; Deng X; Jiang H; Wu J; Zhou C; Guo Y; Yao Y; Zeng R; Xu G
    Cell Death Dis; 2019 Mar; 10(4):291. PubMed ID: 30926787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CU06-1004 alleviates oxidative stress and inflammation on folic acid-induced acute kidney injury in mice.
    Bae CR; Kim Y; Kwon YG
    J Pharmacol Sci; 2024 Feb; 154(2):77-85. PubMed ID: 38246731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term dexamethasone treatment transiently, but not permanently, attenuates fibrosis after acute-to-chronic kidney injury.
    Moonen L; Geryl H; D'Haese PC; Vervaet BA
    BMC Nephrol; 2018 Dec; 19(1):343. PubMed ID: 30509215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment with Roxadustat (FG-4592) Attenuates Folic Acid-Induced Kidney Injury through Antiferroptosis via Akt/GSK-3
    Li X; Zou Y; Xing J; Fu YY; Wang KY; Wan PZ; Zhai XY
    Oxid Med Cell Longev; 2020; 2020():6286984. PubMed ID: 32051732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT6 Deficiency Attenuates Myeloid Fibroblast Activation and Macrophage Polarization in Experimental Folic Acid Nephropathy.
    Jiao B; An C; Du H; Tran M; Wang P; Zhou D; Wang Y
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One dose of cyclosporine A is protective at initiation of folic acid-induced acute kidney injury in mice.
    Wen X; Peng Z; Li Y; Wang H; Bishop JV; Chedwick LR; Singbartl K; Kellum JA
    Nephrol Dial Transplant; 2012 Aug; 27(8):3100-9. PubMed ID: 22294776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remimazolam reduces sepsis-associated acute liver injury by activation of peripheral benzodiazepine receptors and p38 inhibition of macrophages.
    Fang H; Zhang Y; Wang J; Li L; An S; Huang Q; Chen Z; Yang H; Wu J; Zeng Z
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108331. PubMed ID: 34810122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological Inhibition of STING/TBK1 Signaling Attenuates Myeloid Fibroblast Activation and Macrophage to Myofibroblast Transition in Renal Fibrosis.
    Zeng H; Gao Y; Yu W; Liu J; Zhong C; Su X; Wen S; Liang H
    Front Pharmacol; 2022; 13():940716. PubMed ID: 35924048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF or EGFR inhibition equally block AKI-to-CKD transition: opportunities for etanercept treatment.
    Abdelmageed MM; Kefaloyianni E; Arthanarisami A; Komaru Y; Atkinson JJ; Herrlich A
    Nephrol Dial Transplant; 2023 May; 38(5):1139-1150. PubMed ID: 36269313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of IL-18 reduces renal fibrosis after ischemia-reperfusion.
    Liang H; Xu F; Zhang T; Huang J; Guan Q; Wang H; Huang Q
    Biomed Pharmacother; 2018 Oct; 106():879-889. PubMed ID: 30119258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The IL-4 receptor α has a critical role in bone marrow-derived fibroblast activation and renal fibrosis.
    Liang H; Zhang Z; Yan J; Wang Y; Hu Z; Mitch WE; Wang Y
    Kidney Int; 2017 Dec; 92(6):1433-1443. PubMed ID: 28739140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.